Stock DNA
Pharmaceuticals & Biotechnology
CAD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.10
68.86%
-0.03
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Oct 2024)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-60.0%
0%
-60.0%
6 Months
-60.0%
0%
-60.0%
1 Year
-75.0%
0%
-75.0%
2 Years
-92.0%
0%
-92.0%
3 Years
-93.33%
0%
-93.33%
4 Years
-98.11%
0%
-98.11%
5 Years
-90.48%
0%
-90.48%
Jack Nathan Medical Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
114.93%
EBIT Growth (5y)
-257.16%
EBIT to Interest (avg)
-5.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.10
Sales to Capital Employed (avg)
5.71
Tax Ratio
9.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.03
EV to EBIT
-1.88
EV to EBITDA
-2.28
EV to Capital Employed
11.49
EV to Sales
0.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-612.40%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Oct'24 - QoQ
Oct'24
Jul'24
Change(%)
Net Sales
5.20
5.40
-3.70%
Operating Profit (PBDIT) excl Other Income
-1.00
-1.30
23.08%
Interest
0.60
0.50
20.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.80
-2.30
21.74%
Operating Profit Margin (Excl OI)
-245.20%
-311.10%
6.59%
USD in Million.
Net Sales
QoQ Growth in quarter ended Oct 2024 is -3.70% vs 1.89% in Jul 2024
Consolidated Net Profit
QoQ Growth in quarter ended Oct 2024 is 21.74% vs -21.05% in Jul 2024
Annual Results Snapshot (Consolidated) - Jan'24
Jan'24
Jan'23
Change(%)
Net Sales
19.10
15.50
23.23%
Operating Profit (PBDIT) excl Other Income
-4.10
-4.20
2.38%
Interest
1.30
0.40
225.00%
Exceptional Items
-1.10
-1.50
26.67%
Consolidate Net Profit
-6.60
-6.90
4.35%
Operating Profit Margin (Excl OI)
-277.90%
-342.30%
6.44%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2024 is 23.23% vs 61.46% in Jan 2023
Consolidated Net Profit
YoY Growth in year ended Jan 2024 is 4.35% vs 13.75% in Jan 2023
About Jack Nathan Medical Corp. 
Jack Nathan Medical Corp.
Pharmaceuticals & Biotechnology
Jack Nathan Medical Corp., formerly Woodbridge Ventures Inc., is a Canada-based healthcare company. The Company provides patient care, through physicians, and a variety of medical services, technology and programs. The Company has approximately 76 medical centers across Canada including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec, as well as six locations in Mexico. It provides cloud-based medication-management software platform, which is available on mobile devices and Web platforms. The platforms support the secure digital communication, record maintenance and workflow of resident-related orders and documentation.
Company Coordinates 
Company Details
181 University Avenue, Suite 800 , TORONTO ON : M5H 2X7
Registrar Details






